Skip to main content
. 2021 Jan 1;11(5):2098–2107. doi: 10.7150/thno.48027

Table 1.

Clinical characteristics of the PD-L1 expression dataset

Characteristics Total (n = 939) Training cohort (n = 750) Validation cohort (n = 93) P Value* Test cohort (n = 96) P Value**
Age, year, mean ± SD 58.8 ± 10.7 58.9 ± 10.7 58.0 ± 10.3 0.462 59.0 ± 11.3 0.892
Gender, n (%) 0.838 0.408
Male 576 (61.3) 455 (60.7) 58 (62.4) 63 (65.6)
Female 363 (38.7) 295 (39.3) 35 (37.6) 33 (34.4)
Smoking status, n (%) 0.938 0.409
Never 432 (46.0) 348 (46.4) 43 (46.2) 41 (42.7)
Occasionally 374 (39.8) 300 (40.0) 36 (38.7) 38 (39.6)
Constantly 95 (10.1) 74 (9.7) 11 (11.8) 10 (10.4)
Unknown 38 (4.0) 28 (3.7) 3 (3.2) 7 (7.2)
Family history of cancer, n (%) 0.686 0.437
No 764 (81.4) 610 (81.3) 79 (84.9) 75 (78.1)
Yes 139 (14.8) 113 (15.1) 11 (11.8) 15 (15.6)
Unknown 36 (3.8) 27 (3.6) 3 (3.2) 6 (6.3)
PD-L1 expression, n (%) 0.988 0.995
≥ 50% 328 (34.9) 261 (34.8) 33 (35.5) 34 (35.4)
< 50% 611 (65.1) 489 (65.2) 60 (64.5) 62 (64.6)

Categorical data are shown as numbers (%) and continuous data as mean ± SD;

*The P value is the test result of the training cohort and the validation cohort;

**The P value is the test result of the training cohort and the test cohort.